glp 1 for intracranial hypertension Recurrent Idiopathic Hypertension–Related Papilledema After Abrupt Discontinuation of Semaglutide: JNO Article: https://bit.ly/JNO_recurr_IIH_GLP1RA #brain #eye #vision #research #Neurology #NeuroOphth #Ophthalmology #Medicine #Papilledema The effect of GLP-1 agonist

New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an important role in reducing the risk of multiple obesity-related diseases.

GLP-2 analogs positively influence nutrient absorption in animal models and humans, although continued therapy is likely needed for sustained effects

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Amer...

The stock market is not an indication of quality or access or moving toward the Quintuple Aim in health care

PlexusDx offers compounded tirzepatide injections starting at $249/month with no insurance required, serving all 50 states

Regain Control with Plant-Powered Balance